About Enfusion
Enfusion is a company based in Chicago (United States) founded in 1997 was acquired by Clearwater in January 2025. Enfusion has raised $150 million across 2 funding rounds from investors including Clearwater Analytics, ICONIQ Growth and FTV Capital. The company has 599 employees as of October 31, 2024. Enfusion offers products and services including Portfolio Management, Order and Execution Management, Accounting, Analytics, and Managed Services. Enfusion operates in a competitive market with competitors including GAIN Capital, ION Group, Capitolis, Nasdaq Private Market and SunGard, among others.
- Headquarter Chicago, United States
- Employees 599 as on 31 Oct, 2024
- Stage Public
-
Sectors
Technology
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$187.52 M (USD)73as on Dec 31, 2024
-
Net Profit
$2.82 M (USD)-53as on Dec 31, 2024
-
EBITDA
$6.16 M (USD)-48as on Dec 31, 2024
-
Total Equity Funding
$150 M (USD)
in 2 rounds
-
Latest Funding Round
$150 M (USD), Series D
Jan 11, 2021
-
Investors
Clearwater Analytics
& 3 more
-
Employee Count
599
as on Oct 31, 2024
-
Acquired by
Clearwater
(Jan 13, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enfusion
Enfusion offers a comprehensive portfolio of products and services, including Portfolio Management, Order and Execution Management, Accounting, Analytics, and Managed Services.
Tool for real-time portfolio construction and management.
System for trade order handling with compliance features.
Platform for automated general ledger reconciliation.
Service for investment performance and risk insights.
Outsourced middle and back-office processes.
People of Enfusion
Unlock access to complete
Unlock access to complete
Software Development Team
79 people
Product Management Team
32 people
Sales and Marketing
31 people
Leadership Team
29 people
Senior Team
11 people
Head Team
7 people
Board Team
6 people
Creative and Marketing Team
6 people
Unlock access to complete
Funding Insights of Enfusion
Enfusion has successfully raised a total of $150M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $150 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series D — $150.0M
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Series D - Enfusion | Valuation | ICONIQ Growth | |
| Jan, 2017 | Amount | Series A - Enfusion | Valuation |
investors |
Investors in Enfusion
Enfusion has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Clearwater Analytics, ICONIQ Growth and FTV Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided to technology companies by the firm.
|
Founded Year | Domain | Location | |
|
Private equity investment firm
|
Founded Year | Domain | Location | |
|
Global private equity investments are managed with long-term focus.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Enfusion
Financial Statements - Enfusion
Enfusion Comparisons
Competitors of Enfusion
Enfusion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GAIN Capital, ION Group, Capitolis, Nasdaq Private Market and SunGard, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
White-label front-end trading solutions for capital markets are provided.
|
|
| domain | founded_year | HQ Location |
Treasury management solutions are provided for financial institutions and banks.
|
|
| domain | founded_year | HQ Location |
Trade management solutions are provided for investors in capital markets.
|
|
| domain | founded_year | HQ Location |
White-labelled software for private market investments is provided to organizations.
|
|
| domain | founded_year | HQ Location |
Enterprise Software
|
|
| domain | founded_year | HQ Location |
Software suite offered to investment professionals for structured product access.
|
Frequently Asked Questions about Enfusion
Enfusion was founded in 1997 and raised its 1st funding round 20 years after it was founded.
Enfusion is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Enfusion is a funded company, having raised a total of $150M across 2 funding rounds to date.
As of Oct 31, 2024, the latest employee count at Enfusion is 599.
Annual revenue of Enfusion is $187.52M as on Dec 31, 2024.
Enfusion was founded in 1997 in Chicago, United States, focusing on the capital markets sector. SaaS-based tools are offered for trade execution, portfolio management, order handling, accounting, compliance, risk evaluation, account reconciliation, and portfolio monitoring. Back-office support is extended to family offices, funds, and asset managers through these integrated operations.
Enfusion's top competitors include Capitolis, Halo Investing and M-DAQ.
Enfusion offers Portfolio Management, Order and Execution Management, Accounting, Analytics, and Managed Services.
Enfusion has 4 investors. Key investors include Clearwater Analytics, ICONIQ Growth, FTV Capital, and Hillhouse.